The detectability of ketamine through drug screening is not guaranteed by standard panels. Routine drug tests often target substances such as opioids, cannabinoids, amphetamines, cocaine, and phencyclidine. Consequently, specialized assays are typically required for its detection. The presence of ketamine and its metabolites in bodily fluids, such as urine or blood, depends on factors like dosage, frequency of use, individual metabolism, and the sensitivity of the analytical method employed.
Accurate identification of substance use has significance in various settings. In clinical environments, confirmation is essential for monitoring patient adherence to prescribed treatments and for diagnosing potential misuse. Legally, such confirmation may be critical in forensic investigations or workplace compliance programs. Historically, the development of analytical techniques for identifying psychoactive compounds has evolved alongside increasing awareness of substance use and its associated consequences.